In certain cancer types, such as neuroblastoma, hepatocellular carcinoma, lung adenocarcinoma, and endometrial cancer, KDM6B functions as a tumor suppressor, and its expression is associated with improved survival rates and prognoses (138–141). The gene discussed is KDM6B; the disease is cancer.